ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志

• 论文 • 上一篇    下一篇

移植肾肾小球病的诊断和治疗进展

  

  • 出版日期:2020-06-28 发布日期:2020-07-07

Update on diagnosis and treatment of transplant glomerulopathy

  • Online:2020-06-28 Published:2020-07-07

摘要: 移植肾肾小球病(TG)是以移植肾肾小球基膜分层为特征的一组疾病,免疫荧光通常呈阴性,仅部分患者可伴IgA阳性。TG早期临床表现隐匿,多通过程序性活检发现。TG是影响移植肾远期生存率的重要因素,其典型临床表现包括肾病范围内的蛋白尿、高血压和肾小球滤过率下降。抗体介导的排斥反应是导致TG的最主要原因,其他原因包括自身抗体、细胞性排斥反应、血栓性微血管病和丙型肝炎病毒感染等。TG重在预防,目前仍没有确切有效的治疗手段,早期干预可能取得较好的效果。

关键词: 肾移植, 移植肾肾小球病, 临床病理, 治疗, 预后

Abstract: Transplant glomerulopathy (TG) is a group of disorders that are characterized histopathologically by glomerular capillary loop duplication with pauciimmunocomplex deposition.Cardinal clinical symptoms of TG included proteinuria,serum creatinine elevation and hypertension.It is the leading cause of longterm allograft failure.Although chronic and repetitive endothelial injury is conceived to be the contributing factor,the exact pathomechanism of TG remains elusive.Chronic active antibodymediated rejection (cABMR) is the predominant etiology for TG,with alloantibody,T cellmediated rejection (TCMR),thrombotic microangiopathy (TMA) and hepatitis C virus (HCV) infection have all been reported to cause TG.Early intervention may obtain a more desirable result for TG that predominantly targets prevention.

Key words: renal transplantation,transplant glomerulopathy,clinicopathology spectra,treatment  , prognosis